Those receiving a single treatment reported abstaining from drug use for a median of 5.5 months, while participants who received multiple treatments maintained abstinence for a median of 8.4 months.

Moderate and high SUD risk was significantly increased among people living with HIV during the COVID-19 pandemic, between 2018 and 2022.

A UCL study found that lamotrigine is as effective as mexiletine for treating non-dystrophic myotonia, a rare muscle disorder ...

If you provide methadone treatment or other substance-use disorder treatments in jails, will it reduce people from going back ...

Each year, Topeka City Council members allocate alcohol tax funds towards addressing substance abuse. Here's how they will be ...

Agents like semaglutide show promise for treatment of substance use disorders. Inaccessibility of GLP-1 agonists due to high ...

WALKER COUNTY, Ala. (WMBA) — The Walker County Jail received new technology to further treat substance use disorder. The jail ...

A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of ...

The $1.2 million in Health Resources and Services Administration federal grants is to bring more behavioral health options ...

A complex problem like we are seeing on the streets of most Canadian cities requires a full suite of solutions ...

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) held “The Phoenix,” an event to highlight the power of ...